Bellerophon Therapeutics, Inc.: cashflow_operating
| Value | {"amount": -8170000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "currency": "USD"} |
|---|---|
| Period | 2017-01-01 – 2017-06-30 |
| Status | superseded |
| Entity | Bellerophon Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7a4e34fb-19fc-4093-930a-e42e1e0f4cdd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001600132-17-000082 · Open the official SEC filing →Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001600132/cashflow-operating/2017-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7a4e34fb-19fc-4093-930a-e42e1e0f4cdd
History
- no predecessors — first report